HEADER IMMUNE SYSTEM 26-MAY-25 9OSX TITLE PFCYRPA-EM EPITOPE MIMIC BOUND TO MONOCLONAL ANTIBODY CY.004 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PFCYRPA-EM; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: CY.004 HEAVY CHAIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: CY.004 LIGHT CHAIN; COMPND 11 CHAIN: C; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 3 ORGANISM_TAXID: 32630; SOURCE 4 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 5 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 9 ORGANISM_COMMON: CHICKEN; SOURCE 10 ORGANISM_TAXID: 9031; SOURCE 11 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 12 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 14 MOL_ID: 3; SOURCE 15 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 16 ORGANISM_COMMON: CHICKEN; SOURCE 17 ORGANISM_TAXID: 9031; SOURCE 18 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 19 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 20 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS PFCYRPA, BLOOD-STAGE MALARIA, VACCINE IMMUNOGEN DESIGN, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR N.ALAM,M.K.HIGGINS REVDAT 1 24-DEC-25 9OSX 0 JRNL AUTH N.ALAM,M.K.HIGGINS JRNL TITL STRUCTURE-GUIDED DESIGN OF A PFCYRPA-BASED VACCINE AGAINST JRNL TITL 2 BLOOD-STAGE MALARIA JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.67 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.67 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 173.21 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 3 NUMBER OF REFLECTIONS : 16120 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.256 REMARK 3 R VALUE (WORKING SET) : 0.254 REMARK 3 FREE R VALUE : 0.292 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.280 REMARK 3 FREE R VALUE TEST SET COUNT : 851 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4114 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 94 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 57.05 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -20.8413 1.7858 43.7894 REMARK 3 T TENSOR REMARK 3 T11: 0.3995 T22: 0.3575 REMARK 3 T33: 0.4209 T12: -0.0744 REMARK 3 T13: 0.0192 T23: 0.0245 REMARK 3 L TENSOR REMARK 3 L11: 0.1270 L22: 0.1406 REMARK 3 L33: 1.8425 L12: -0.0909 REMARK 3 L13: 0.2615 L23: -0.1022 REMARK 3 S TENSOR REMARK 3 S11: 0.0136 S12: 0.0088 S13: -0.0250 REMARK 3 S21: 0.0046 S22: -0.0451 S23: 0.0102 REMARK 3 S31: 0.0809 S32: 0.0615 S33: 0.0367 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9OSX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-MAY-25. REMARK 100 THE DEPOSITION ID IS D_1000296282. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-MAY-23 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92124 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 XE 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16178 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 173.210 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.70 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM ACETATE, PH 4.0, 0.2 M REMARK 280 AMMONIUM ACETATE, 15% W/V PEG4000, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 43.80750 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 18.98800 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 43.80750 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 18.98800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 GLY A 2 REMARK 465 GLY A 3 REMARK 465 GLY A 4 REMARK 465 SER A 5 REMARK 465 ALA A 6 REMARK 465 SER A 7 REMARK 465 ILE A 8 REMARK 465 SER A 118 REMARK 465 GLY A 119 REMARK 465 GLY A 120 REMARK 465 GLY A 121 REMARK 465 SER A 122 REMARK 465 GLU A 123 REMARK 465 GLN A 124 REMARK 465 LYS A 125 REMARK 465 HIS A 126 REMARK 465 HIS A 127 REMARK 465 HIS A 128 REMARK 465 HIS A 129 REMARK 465 HIS A 130 REMARK 465 HIS A 131 REMARK 465 SER B 159 REMARK 465 SER B 160 REMARK 465 LYS B 161 REMARK 465 SER B 162 REMARK 465 THR B 163 REMARK 465 SER B 164 REMARK 465 GLY B 165 REMARK 465 SER B 247 REMARK 465 CYS B 248 REMARK 465 ASP B 249 REMARK 465 LYS B 250 REMARK 465 THR B 251 REMARK 465 HIS B 252 REMARK 465 THR B 253 REMARK 465 CYS B 254 REMARK 465 PRO B 255 REMARK 465 PRO B 256 REMARK 465 CYS B 257 REMARK 465 PRO B 258 REMARK 465 ALA B 259 REMARK 465 PRO B 260 REMARK 465 GLU B 261 REMARK 465 LEU B 262 REMARK 465 LEU B 263 REMARK 465 GLY B 264 REMARK 465 GLY B 265 REMARK 465 PRO B 266 REMARK 465 SER B 267 REMARK 465 VAL B 268 REMARK 465 PHE B 269 REMARK 465 LEU B 270 REMARK 465 PHE B 271 REMARK 465 PRO B 272 REMARK 465 PRO B 273 REMARK 465 LYS B 274 REMARK 465 PRO B 275 REMARK 465 LYS B 276 REMARK 465 ASP B 277 REMARK 465 THR B 278 REMARK 465 LEU B 279 REMARK 465 MET B 280 REMARK 465 ILE B 281 REMARK 465 SER B 282 REMARK 465 ARG B 283 REMARK 465 THR B 284 REMARK 465 PRO B 285 REMARK 465 GLU B 286 REMARK 465 VAL B 287 REMARK 465 THR B 288 REMARK 465 CYS B 289 REMARK 465 VAL B 290 REMARK 465 VAL B 291 REMARK 465 VAL B 292 REMARK 465 ASP B 293 REMARK 465 VAL B 294 REMARK 465 SER B 295 REMARK 465 HIS B 296 REMARK 465 GLU B 297 REMARK 465 ASP B 298 REMARK 465 PRO B 299 REMARK 465 GLU B 300 REMARK 465 VAL B 301 REMARK 465 LYS B 302 REMARK 465 PHE B 303 REMARK 465 ASN B 304 REMARK 465 TRP B 305 REMARK 465 TYR B 306 REMARK 465 VAL B 307 REMARK 465 ASP B 308 REMARK 465 GLY B 309 REMARK 465 VAL B 310 REMARK 465 GLU B 311 REMARK 465 VAL B 312 REMARK 465 HIS B 313 REMARK 465 ASN B 314 REMARK 465 ALA B 315 REMARK 465 LYS B 316 REMARK 465 THR B 317 REMARK 465 LYS B 318 REMARK 465 PRO B 319 REMARK 465 ARG B 320 REMARK 465 GLU B 321 REMARK 465 GLU B 322 REMARK 465 GLN B 323 REMARK 465 TYR B 324 REMARK 465 ASN B 325 REMARK 465 SER B 326 REMARK 465 THR B 327 REMARK 465 TYR B 328 REMARK 465 ARG B 329 REMARK 465 VAL B 330 REMARK 465 VAL B 331 REMARK 465 SER B 332 REMARK 465 VAL B 333 REMARK 465 LEU B 334 REMARK 465 THR B 335 REMARK 465 VAL B 336 REMARK 465 LEU B 337 REMARK 465 HIS B 338 REMARK 465 GLN B 339 REMARK 465 ASP B 340 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 64.47 -160.08 REMARK 500 GLU A 38 25.82 -148.37 REMARK 500 LYS A 50 -96.80 56.90 REMARK 500 LYS A 108 -47.76 -132.03 REMARK 500 ALA A 113 88.35 -158.94 REMARK 500 ASP B 47 98.87 -68.79 REMARK 500 SER B 147 -167.66 -101.59 REMARK 500 CYS B 172 112.03 -169.34 REMARK 500 ASP B 176 75.22 63.10 REMARK 500 PRO B 179 -163.68 -78.78 REMARK 500 PRO B 181 109.45 -54.34 REMARK 500 TYR C 47 -151.94 -103.01 REMARK 500 ASN C 68 -46.04 71.84 REMARK 500 SER C 86 49.54 -106.48 REMARK 500 ALA C 101 178.35 179.50 REMARK 500 ASN C 107 -165.46 -165.26 REMARK 500 ASN C 155 74.79 52.71 REMARK 500 REMARK 500 REMARK: NULL DBREF 9OSX A 1 131 PDB 9OSX 9OSX 1 131 DBREF 9OSX B 20 340 PDB 9OSX 9OSX 20 340 DBREF 9OSX C 23 231 PDB 9OSX 9OSX 23 231 SEQRES 1 A 131 GLY GLY GLY GLY SER ALA SER ILE LYS ASN PRO VAL PRO SEQRES 2 A 131 CYS ILE ARG ASP MET PHE PHE ILE TYR LYS ASN GLU LEU SEQRES 3 A 131 TYR ASN ILE CYS LEU ASN ASP LEU LYS GLY GLU GLU ASP SEQRES 4 A 131 GLU ILE HIS ILE TYR VAL GLN LYS LYS VAL LYS ASP SER SEQRES 5 A 131 TRP ILE THR LEU ASN ASP LEU PHE LYS GLU THR ASP LEU SEQRES 6 A 131 THR GLY ARG PRO HIS ILE PHE THR TYR ILE GLN GLU ASP SEQRES 7 A 131 GLU ILE ASN ILE LEU LEU CYS GLU ASP GLU GLU PHE SER SEQRES 8 A 131 ASN ARG LYS LYS ASP LEU THR CYS HIS ARG PHE TYR SER SEQRES 9 A 131 ASN ASP GLY LYS GLU PHE ASN ASN ALA GLU ILE THR ILE SEQRES 10 A 131 SER GLY GLY GLY SER GLU GLN LYS HIS HIS HIS HIS HIS SEQRES 11 A 131 HIS SEQRES 1 B 321 ALA VAL THR LEU ASP GLU SER GLY GLY GLY LEU GLN THR SEQRES 2 B 321 PRO GLY GLY ALA LEU SER LEU VAL CYS LYS ALA SER GLY SEQRES 3 B 321 PHE ASP PHE SER SER TYR ALA MET GLY TRP VAL ARG GLN SEQRES 4 B 321 ALA PRO GLY LYS GLY LEU GLU TYR VAL ALA GLY ILE ARG SEQRES 5 B 321 ASN ASP GLY SER PHE THR LEU TYR THR PRO ALA VAL LYS SEQRES 6 B 321 GLY ARG ALA THR ILE SER ARG ASP ASN GLY GLN SER THR SEQRES 7 B 321 VAL ARG LEU GLN LEU ASN ASN LEU ARG ALA GLU ASP THR SEQRES 8 B 321 ALA THR TYR PHE CYS THR LYS SER ALA ASP ASP GLY GLY SEQRES 9 B 321 HIS TYR SER ASP PHE SER GLY GLU ILE ASP ALA TRP GLY SEQRES 10 B 321 HIS GLY THR GLU VAL ILE VAL SER SER ALA SER THR LYS SEQRES 11 B 321 GLY PRO SER VAL PHE PRO LEU ALA PRO SER SER LYS SER SEQRES 12 B 321 THR SER GLY GLY THR ALA ALA LEU GLY CYS LEU VAL LYS SEQRES 13 B 321 ASP TYR PHE PRO GLU PRO VAL THR VAL SER TRP ASN SER SEQRES 14 B 321 GLY ALA LEU THR SER GLY VAL HIS THR PHE PRO ALA VAL SEQRES 15 B 321 LEU GLN SER SER GLY LEU TYR SER LEU SER SER VAL VAL SEQRES 16 B 321 THR VAL PRO SER SER SER LEU GLY THR GLN THR TYR ILE SEQRES 17 B 321 CYS ASN VAL ASN HIS LYS PRO SER ASN THR LYS VAL ASP SEQRES 18 B 321 LYS LYS VAL GLU PRO LYS SER CYS ASP LYS THR HIS THR SEQRES 19 B 321 CYS PRO PRO CYS PRO ALA PRO GLU LEU LEU GLY GLY PRO SEQRES 20 B 321 SER VAL PHE LEU PHE PRO PRO LYS PRO LYS ASP THR LEU SEQRES 21 B 321 MET ILE SER ARG THR PRO GLU VAL THR CYS VAL VAL VAL SEQRES 22 B 321 ASP VAL SER HIS GLU ASP PRO GLU VAL LYS PHE ASN TRP SEQRES 23 B 321 TYR VAL ASP GLY VAL GLU VAL HIS ASN ALA LYS THR LYS SEQRES 24 B 321 PRO ARG GLU GLU GLN TYR ASN SER THR TYR ARG VAL VAL SEQRES 25 B 321 SER VAL LEU THR VAL LEU HIS GLN ASP SEQRES 1 C 209 ALA LEU THR GLN PRO SER SER VAL SER ALA ASN PRO GLY SEQRES 2 C 209 GLU THR VAL LYS ILE THR CYS SER GLY SER THR TYR ASN SEQRES 3 C 209 TYR GLY TRP TYR GLN GLN LYS SER PRO GLY SER ALA PRO SEQRES 4 C 209 VAL THR VAL ILE TYR TYR ASN ASP LYS ARG PRO SER ASP SEQRES 5 C 209 ILE PRO SER ARG PHE SER GLY SER LYS SER GLY SER THR SEQRES 6 C 209 GLY THR LEU THR ILE THR GLY VAL GLN ALA GLU ASP GLU SEQRES 7 C 209 ALA VAL TYR TYR CYS GLY ASN SER ASP SER ARG ASN VAL SEQRES 8 C 209 ALA PHE GLY ALA GLY THR THR LEU THR VAL LEU ARG THR SEQRES 9 C 209 VAL ALA ALA PRO SER VAL PHE ILE PHE PRO PRO SER ASP SEQRES 10 C 209 GLU GLN LEU LYS SER GLY THR ALA SER VAL VAL CYS LEU SEQRES 11 C 209 LEU ASN ASN PHE TYR PRO ARG GLU ALA LYS VAL GLN TRP SEQRES 12 C 209 LYS VAL ASP ASN ALA LEU GLN SER GLY ASN SER GLN GLU SEQRES 13 C 209 SER VAL THR GLU GLN ASP SER LYS ASP SER THR TYR SER SEQRES 14 C 209 LEU SER SER THR LEU THR LEU SER LYS ALA ASP TYR GLU SEQRES 15 C 209 LYS HIS LYS VAL TYR ALA CYS GLU VAL THR HIS GLN GLY SEQRES 16 C 209 LEU SER SER PRO VAL THR LYS SER PHE ASN ARG GLY GLU SEQRES 17 C 209 CYS FORMUL 4 HOH *94(H2 O) HELIX 1 AA1 PHE A 60 THR A 63 5 4 HELIX 2 AA2 ASP B 47 TYR B 51 5 5 HELIX 3 AA3 PRO B 81 LYS B 84 5 4 HELIX 4 AA4 ARG B 106 THR B 110 5 5 HELIX 5 AA5 TYR B 125 GLY B 130 1 6 HELIX 6 AA6 SER B 188 ALA B 190 5 3 HELIX 7 AA7 SER B 219 LEU B 221 5 3 HELIX 8 AA8 PRO B 234 ASN B 236 5 3 HELIX 9 AA9 GLN C 96 GLU C 100 5 5 HELIX 10 AB1 SER C 138 LYS C 143 1 6 HELIX 11 AB2 LYS C 200 GLU C 204 1 5 SHEET 1 AA1 4 ILE A 15 TYR A 22 0 SHEET 2 AA1 4 GLU A 25 ASN A 32 -1 O TYR A 27 N PHE A 20 SHEET 3 AA1 4 HIS A 42 VAL A 49 -1 O TYR A 44 N CYS A 30 SHEET 4 AA1 4 SER A 52 ASP A 58 -1 O LEU A 56 N VAL A 45 SHEET 1 AA2 4 PRO A 69 GLN A 76 0 SHEET 2 AA2 4 GLU A 79 GLU A 86 -1 O CYS A 85 N HIS A 70 SHEET 3 AA2 4 THR A 98 SER A 104 -1 O THR A 98 N GLU A 86 SHEET 4 AA2 4 ASN A 111 THR A 116 -1 O ILE A 115 N CYS A 99 SHEET 1 AA3 4 THR B 22 SER B 26 0 SHEET 2 AA3 4 ALA B 36 SER B 44 -1 O LYS B 42 N ASP B 24 SHEET 3 AA3 4 THR B 97 ASN B 103 -1 O LEU B 100 N LEU B 39 SHEET 4 AA3 4 ALA B 87 ASP B 92 -1 N SER B 90 O ARG B 99 SHEET 1 AA4 6 LEU B 30 GLN B 31 0 SHEET 2 AA4 6 THR B 139 VAL B 143 1 O ILE B 142 N GLN B 31 SHEET 3 AA4 6 ALA B 111 SER B 118 -1 N TYR B 113 O THR B 139 SHEET 4 AA4 6 MET B 53 GLN B 58 -1 N VAL B 56 O PHE B 114 SHEET 5 AA4 6 LEU B 64 ILE B 70 -1 O VAL B 67 N TRP B 55 SHEET 6 AA4 6 THR B 77 TYR B 79 -1 O LEU B 78 N GLY B 69 SHEET 1 AA5 4 LEU B 30 GLN B 31 0 SHEET 2 AA5 4 THR B 139 VAL B 143 1 O ILE B 142 N GLN B 31 SHEET 3 AA5 4 ALA B 111 SER B 118 -1 N TYR B 113 O THR B 139 SHEET 4 AA5 4 ILE B 132 TRP B 135 -1 O ALA B 134 N LYS B 117 SHEET 1 AA6 4 SER B 152 LEU B 156 0 SHEET 2 AA6 4 THR B 167 TYR B 177 -1 O LEU B 173 N PHE B 154 SHEET 3 AA6 4 TYR B 208 PRO B 217 -1 O LEU B 210 N VAL B 174 SHEET 4 AA6 4 VAL B 195 THR B 197 -1 N HIS B 196 O VAL B 213 SHEET 1 AA7 4 SER B 152 LEU B 156 0 SHEET 2 AA7 4 THR B 167 TYR B 177 -1 O LEU B 173 N PHE B 154 SHEET 3 AA7 4 TYR B 208 PRO B 217 -1 O LEU B 210 N VAL B 174 SHEET 4 AA7 4 VAL B 201 LEU B 202 -1 N VAL B 201 O SER B 209 SHEET 1 AA8 3 VAL B 182 TRP B 186 0 SHEET 2 AA8 3 TYR B 226 HIS B 232 -1 O ASN B 229 N SER B 185 SHEET 3 AA8 3 THR B 237 VAL B 243 -1 O LYS B 241 N CYS B 228 SHEET 1 AA9 5 SER C 29 ALA C 32 0 SHEET 2 AA9 5 THR C 119 VAL C 123 1 O THR C 120 N VAL C 30 SHEET 3 AA9 5 ALA C 101 SER C 108 -1 N ALA C 101 O LEU C 121 SHEET 4 AA9 5 GLY C 50 GLN C 54 -1 N GLN C 54 O VAL C 102 SHEET 5 AA9 5 VAL C 62 ILE C 65 -1 O ILE C 65 N TRP C 51 SHEET 1 AB1 4 SER C 29 ALA C 32 0 SHEET 2 AB1 4 THR C 119 VAL C 123 1 O THR C 120 N VAL C 30 SHEET 3 AB1 4 ALA C 101 SER C 108 -1 N ALA C 101 O LEU C 121 SHEET 4 AB1 4 VAL C 113 PHE C 115 -1 O ALA C 114 N ASN C 107 SHEET 1 AB2 3 VAL C 38 SER C 43 0 SHEET 2 AB2 3 THR C 87 ILE C 92 -1 O LEU C 90 N ILE C 40 SHEET 3 AB2 3 PHE C 79 LYS C 83 -1 N SER C 82 O THR C 89 SHEET 1 AB3 4 SER C 131 PHE C 135 0 SHEET 2 AB3 4 THR C 146 PHE C 156 -1 O LEU C 152 N PHE C 133 SHEET 3 AB3 4 TYR C 190 SER C 199 -1 O SER C 194 N CYS C 151 SHEET 4 AB3 4 SER C 176 VAL C 180 -1 N GLN C 177 O THR C 195 SHEET 1 AB4 3 LYS C 162 VAL C 167 0 SHEET 2 AB4 3 VAL C 208 THR C 214 -1 O ALA C 210 N LYS C 166 SHEET 3 AB4 3 VAL C 222 ASN C 227 -1 O VAL C 222 N VAL C 213 SSBOND 1 CYS A 14 CYS A 30 1555 1555 2.03 SSBOND 2 CYS A 85 CYS A 99 1555 1555 2.04 SSBOND 3 CYS B 41 CYS B 115 1555 1555 2.03 SSBOND 4 CYS B 172 CYS B 228 1555 1555 2.04 SSBOND 5 CYS C 42 CYS C 105 1555 1555 2.04 SSBOND 6 CYS C 151 CYS C 211 1555 1555 2.04 CISPEP 1 PHE B 178 PRO B 179 0 -1.00 CISPEP 2 TYR C 157 PRO C 158 0 4.36 CRYST1 87.615 37.976 173.374 90.00 92.47 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011414 0.000000 0.000493 0.00000 SCALE2 0.000000 0.026332 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005773 0.00000 CONECT 44 189 CONECT 189 44 CONECT 650 768 CONECT 768 650 CONECT 1062 1632 CONECT 1632 1062 CONECT 1980 2394 CONECT 2394 1980 CONECT 2677 3159 CONECT 3159 2677 CONECT 3486 3965 CONECT 3965 3486 MASTER 392 0 0 11 52 0 0 6 4208 3 12 53 END